May 30, 2019

Dr Jonathan Brotchie will attend the Gordon Research Conference on Cannabinoid Function in the CNS on 21st-26th July in Barcelona, Spain.  Abide Therapeutics and Atuka will present a poster entitled “The selective monoacylglycerol lipase inhibitor ABD-101970 reduces L-DOPA-induced dyskinesia in MPTP-lesioned macaques” at the meeting.

More information on the conference can be found here

Description & References:

Product Spec:

CAS No.:

Molecular Structure: